study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
LONG-LON06-01,2020,randomized controlled trial,SMD,0.2912,0.106,0.4764,76,77,some concerns,10.1234/long-lon06-01,longevity-journal-01,mitochondrial_function,Adults with mitochondrial function concerns,Transient headache,8
LONG-LON06-02,2011,randomized controlled trial,SMD,0.2858,0.1182,0.4534,89,92,some concerns,10.1234/long-lon06-02,longevity-journal-02,mitochondrial_function,Adults with mitochondrial function concerns,Mild GI discomfort,13
LONG-LON06-03,2016,randomized controlled trial,SMD,0.2804,0.1304,0.4304,72,76,mixed,10.1234/long-lon06-03,longevity-journal-03,mitochondrial_function,Adults with mitochondrial function concerns,Mild GI discomfort,12
